Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedIntroducing a government funding notice and current operating status for the NIH Clinical Center, along with updating the version to v3.2.0 and removing v3.0.2.SummaryDifference2%
- Check22 days agoChange DetectedRemoved core topics related to drug safety and quality (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), significantly narrowing the page's scope.SummaryDifference0.2%
- Check29 days agoChange Detected- The page now shows a new revision label: v3.0.2, replacing v3.0.1. - A stray “Back to Top” item was removed. Overall, this is a minor update focused on versioning and a small UI change, with no impact on core content, pricing, or availability.SummaryDifference0.1%
- Check36 days agoChange DetectedThe page now shows TETON-1, a Phase 3 trial, with 99 locations (no specific sites listed) and revision v3.0.1 (Sept 2025, estimated) versus the old v3.0.0 (July 2025) with 101 locations and named sites.SummaryDifference1%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check72 days agoChange DetectedThe webpage has updated its version from v2.16.8 to v2.16.11 and has made changes to the dates and locations mentioned, specifically correcting the formatting of St. Louis and Winston Salem.SummaryDifference2%
Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.